Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.
The item "Total-Long-Term-Liabilities" stands at 4.27 Billion Hong Kong Dollars as of 06/30/2025, the highest value since 03/31/2023.
As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Total Long Term Liabilities" stands at 4.27 Billion HKD. This represents no change compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 74.06 percent compared to the value the year prior.
The 1 year change in percent is 74.06.
The 3 year change in percent is -57.01.
The 5 year change in percent is -73.84.
The 10 year change in percent is 190.06.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Long Term Liabilities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Long Term Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Long Term Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Long Term Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Long Term Liabilities | 280,205,508,085.11 |